Surgery Partners, Inc. Sets Stage for Q1 2025 Earnings: Navigating Growth in Outpatient Care

Surgery Partners, Inc. has outlined its financial reporting timeline for the first quarter of 2025, with the earnings release and associated conference call serving as critical touchpoints for investors. Scheduled to be published on May 12, 2025, the results will provide insight into the company’s performance amid ongoing shifts in the healthcare landscape, particularly the rise of outpatient surgical care. The accompanying conference call, starting at 8:30 a.m. ET, promises to offer a deep dive into strategic priorities, operational metrics, and financial health.

Key Earnings Release Details

The company’s first-quarter results will be distributed via GLOBE NEWSWIRE and simultaneously posted on its Investor Relations page at www.surgerypartners.com. Investors are urged to monitor these channels for real-time updates, as the release will include critical financial data such as revenue, EBITDA, and patient volume metrics. The conference call—accessible via dial-in numbers 1-877-451-6152 (domestic) and 1-201-389-0879 (international), with passcode 13752904—will feature management’s commentary on Q1 performance and guidance for the remainder of 2025. A replay of the call will be available until May 26, ensuring accessibility for global stakeholders.

Operational Overview and Market Context

Surgery Partners, founded in 2004 and headquartered in Tennessee, operates a network of over 200 locations across 30 states, specializing in ambulatory surgery centers (ASCs), surgical hospitals, and urgent care facilities. This scale positions it as a leading player in the outpatient care sector, which has gained momentum due to its cost efficiency and patient convenience. The shift toward outpatient procedures—accelerated by post-pandemic healthcare reforms and consumer demand for lower-cost alternatives to hospital care—is a tailwind for firms like Surgery Partners.

The company’s focus on ASCs is particularly strategic. These facilities typically handle elective surgeries, such as orthopedic or ophthalmologic procedures, which have seen steady demand. However, investors will monitor whether Surgery Partners can sustain growth in this segment amid potential reimbursement pressures or regulatory changes.

Financial and Market Dynamics

The upcoming earnings call will likely address how Surgery Partners is navigating macroeconomic challenges, including rising labor costs and evolving payer mixes. A key metric to watch is the same-facility revenue growth, which indicates organic performance. In 2024, the company reported a 4.5% increase in same-facility revenue, but sustaining this growth in 2025 could prove challenging.

Investors should also evaluate management’s commentary on partnerships and acquisitions. The company’s ability to expand its footprint through strategic deals—such as the 2023 acquisition of three ASCs in Texas—will be critical to long-term scalability. Additionally, the rollout of value-based care initiatives, which tie payments to patient outcomes rather than procedure volume, may influence future profitability.

Conclusion: A Pivot Point for Outpatient Care Leadership

Surgery Partners’ Q1 2025 earnings release is a pivotal moment for the company to affirm its position in the outpatient care transformation. With 30-state reach and a focus on high-margin procedures, its financial health hinges on operational efficiency and its capacity to capitalize on industry tailwinds.

Consider this: The U.S. ASC market is projected to grow at a 6.8% CAGR through 2030, reaching $42 billion in revenue, according to Grand View Research. Surgery Partners, with its established network and strategic investments, is well-positioned to capture this growth. However, execution matters. If Q1 results show robust same-facility growth, cost controls, and pipeline momentum, the stock could see upward momentum. Conversely, any signs of margin pressure or regulatory headwinds may temper investor optimism.

The earnings call will also offer clarity on the company’s 2025 outlook. Management’s ability to articulate a clear path to profitability and scalability—backed by data on patient volume, payer mix, and new facility openings—will be vital. For now, Surgery Partners remains a bellwether for the outpatient care boom, and its Q1 results will set the stage for how it navigates the next phase of this evolving sector.